Company intelligence / Profile preview

Sinolead Biotech

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Sinolead Pharma is a global supplier and manufacturer of generic pharmaceuticals, cosmeceuticals, and health supplements, with GMP-certified facilities and a presence in over 5 continents; the company focuses on access to WHO essential drugs for developing markets but does not run its own clinical trials, instead commercializing approved generics and supplements

Therapeutic areas: Metabolic DisordersInfectious DiseasesCardiovascularOtherNeurology
Modalities: Small moleculeBiologicPeptidesProteinCosmeceutical
Industry: Biotech

Beyond the preview

Go deeper on Sinolead Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinolead Biotech.

Explore the full profile